Email mbrisson@nus.edu.sg; mbrisson@uresp.ulaval.ca

Dr. Marc Brisson holds the Tier 1 Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Diseases, and is full professor at Laval University where he leads the Research Group in Mathematical Modeling and Health Economics of Infectious Diseases. His research aims at developing mathematical models that predict the effectiveness and cost-effectiveness of interventions against infectious diseases to help policy decision-making. His current research mainly focuses on HPV vaccination, cervical cancer prevention and respiratory infectious diseases. Dr. Brisson has produced over 150 peer reviewed journal articles (including high impact journals such as The Lancet and The Lancet Family, JNCI, BMJ, and Annals of Internal Medicine), and made over 140 presentations at conferences, external seminars and workshops (over 80 as invited speaker). He has been a scientific consultant for the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the Canadian Partnership Against Cancer (CPAC), the Public Health Agency of Canada (PHAC) and the Canadian Immunization Committee (CIC). He has a BSc in Actuarial Science (1992-1996), a certificate in Statistics (1996) and an MSc in Epidemiology (1996-2001) from Laval University in Quebec City, and a PhD in Health Economics (1999-2004) from City University in London, England.

• Visiting Professor, NUS Saw Swee Hock School of Public Health
• Full Professor, Département de médecine sociale et préventive, Laval University, Canada

• Mathematical Modeling
• Health Economics
• Epidemiology
• Global Health
• Vaccination/Immunization
• Infectious diseases
• Human Papillomavirus
• Respiratory infections
• Varicella and Zoster

• Mathematical Modeling
• Health Economics
• Epidemiology

• 1999-2004 PhD, Health Economics – City University, London, UK
  Dissertation title: Economic Evaluation of Vaccination Programmes: A special reference to varicella vaccination.
  Supervisors Prof. Alistair McGuire, Prof. John Edmunds.
• 1996-2001 MSc, Epidemiology – Laval University, Québec, Canada
  Dissertation title: The role of classical STDs on the transmission dynamics of HIV-1 in the heterosexual population of Montréal.
  Supervisor Dr. Marie-Claude Boily.
• 1996 Certificate, Statistics – Laval University, Québec, Canada
• 1992-1996 BSc, Actuarial Science – Laval University, Québec, Canada

• Tier 1 Canada Research Chair
• Radio-Canada’s Scientist of the Year 2020 along with 3 other winners to represent mathematical modeling during the COVID-19 pandemic

• 2011-2016 Associate Professor, Département de médecine sociale et préventive, Laval University, Canada
• 2006-2011 Assistant Professor, Département de médecine sociale et préventive, Laval University, Canada
• 2005-2006 Adjunct Professor, Département de médecine sociale et préventive, Laval University, Canada

• Bénard, Drolet, , …, Brisson* (Lancet Public Health, 2023). Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis.
• Carazo, Skowronski, Brisson, et al. (Lancet Infectious Disease, 2023). Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
• Brisson*, Kim, Canfell et al. (Lancet, 2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
• Canfell, Kim, Brisson*, et al. (Lancet, 2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
• Brisson*, Bénard, Drolet, et al. (Lancet Public Health, 2020). Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.
• Jit, Brisson*, et al. (Lancet Global Health, 2020). Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. (*Co-developed the model, IF=34, CNCI=7, Percentile=94.6, Citations=286)
• Drolet, Bénard, …, Brisson* (Lancet, 2019). Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
• Drolet, Bénard, …, Brisson* (Lancet Infectious Diseases, 2015). Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.
• Pitman, …, Brisson* (Value in Health & Medical Decision Making, 2012). The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. (*Senior, IF=5, CNCI=5, Percentile=97.8, Citations=372)
• Blicke, Beutels, Brisson, et al. (Medical Decision Making, 2011). Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models: A Practical Guide.
• Jit, Brisson*. (PharmacoEconomics, 2006). Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs.
• Brisson*, Edmunds. (Medical Decision Making, 2003). Economic evaluation of vaccination programs: The impact of herd-immunity.